Kang-Wei Xu

1 article listing Kang-Wei Xu in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Immunogenicity and safety of a recombinant gE-Fc fusion protein subunit vaccine for herpes zoster in adults ≥50 years of age: a randomised, active-controlled, non-inferiority trial Nature Communications